Ixazomib Plus Low-dose Lenalidomide Versus Ixazomib Alone for Maintenance Treatment of High Risk Multiple Myeloma
Clinical trial NCT05722405 · RECRUITING
Trial details
- NCT number
- NCT05722405
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2026-06-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.